Data / Form D filings / Zai Lab Ltd
Zai Lab Ltd: Form D filing
Zai Lab Ltd, a biotechnology company in Cambridge, MA, filed a Form D with the SEC in 2026. The latest, on November 9, 2026, reports $249.9 million sold of a $249.9 million offering to 25 investors.
Find out what Zai Lab Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 314 MAIN STREET 4TH FLOOR, SUITE 10, Cambridge, MA, 02142
- Phone
- +1 857 706 2604
- Industry
- Biotechnology
- Entity type
- Other
- Incorporated in
- Cayman Islands
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1704292
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | New notice | $249,933,600 | $249,933,600 | $0 | 25 | Oct 27, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| SAMANTHA (YING) DU, Ph.D. | Executive Officer, Director | |
| JOHN DAVID DIEKMAN, Ph.D. | Director | |
| RICHARD BRIAN GAYNOR, M.D. | Director | |
| NISA BERNICE WING-YU LEUNG | Director | |
| WILLIAM DAVID LIS | Director | |
| SCOTT WILLIAM MORRISON | Director | |
| LEON OLIVER MOULDER, JR. | Director | |
| MICHEL PERICLES VOUNATSOS | Director | |
| PETER KARL WIRTH, J.D. | Director | |
| YAJING CHEN, Ph.D. | Executive Officer | |
| RAFAEL G. AMADO, M.D. | Executive Officer | |
| F. TY EDMONDSON, J.D. | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
Every Form D from the week of Nov 9, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Zai Lab Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.